Table 3.
Overview of thromboembolic (CTCAE grade 1-5) adverse events
| Group | Adverse event | Area | Days after PHP | treatment | sequalae | n |
|---|---|---|---|---|---|---|
| groupPRO | Ischemic stroke | MCA | 1st | none | none | 1 |
| groupPRO | Ischemic stroke | Bilateral PCA | 4th | none | none | 1 |
| groupPRO | Ischemic stroke | PCA | 6th | none | none | 1 |
| groupPRO | Ischemic stroke | PCA | 5th | none | none | 1 |
| groupPRO | Ischemic stroke; PE; DVT | Basilar artery (stroke) | 2nd |
Thrombectomy, anticoagulation |
none | 1 |
| groupPRO | Ischemic stroke | MCA and ACA | 1st |
Thrombectomy, anticoagulation |
death | 1 |
| groupPRO | Ischemic stroke | MCA (and ACA) | 1st |
Thrombectomy, anticoagulation |
yes | 1 |
| groupPRO | NSTEMI | LAD | 1st | PTCA | none | 1 |
| groupPRO | DVT | Femoral and popliteal vein | 1st week | Anticoagulation | none | 1 |
| groupPRO | PE | Central pulmonary arteries | 2nd | Anticoagulation | none | 1 |
Day of the PHP procedure = 1st day
CTCAE Common Terminology Criteria for Adverse Events, PHP Percutaneous hepatic perfusion, MCA Middle cerebral artery, PCA Posterior cerebral artery, ACA Anterior cerebral artery, NSTEMI Non-ST-segment elevation myocardial infarction, LAD Left anterior descending artery, PTCA Percutaneous transluminal coronary angioplasty, DVT Deep vein thrombosis, PE Pulmonary embolism